Olumiant (generic name: Baricitinib) is an oral medication primarily used to treat moderate to severe rheumatoid arthritis in adults, especially when other treatments haven’t worked well. It belongs to a class of drugs called Janus kinase (JAK) inhibitors.

Mechanism of Action:
Olumiant works by blocking JAK enzymes, which are involved in the inflammatory process. By inhibiting these enzymes, it reduces the activity of immune cells that cause joint inflammation, swelling, and pain in rheumatoid arthritis.

Uses:

• Treatment of moderate to severe rheumatoid arthritis in adults.

• Can be used alone or in combination with other medications like methotrexate.

• Sometimes used for other inflammatory conditions as determined by a doctor.

  Adverse Effects:
  Common side effects may include:

  • Upper respiratory infections (like cold or sinus infections)

  • Nausea

  • Headache

  • High cholesterol levels